Rachel Alcale, Israeli entrepreneur, recognized as a pioneer by FICPI for her medical research
Israeli entrepreneur and founder of a life science start-up called “Novel Concepts Medical”, Rachel Alcale has been named a “Leading Inventor” by the International Federation of Intellectual Property Attorneys (ficpi.org).
His startup significantly won the prize Global Health and Pharma prestigious medical magazine, as an important research and development company in the Middle East 2023, as well as Biotechnologies Awards 2024.
“Novel Concepts Medical” is a medical research and development company founded in 2020 by Rachel Alkaley, PhD, whose aim is to study the role that natural compounds can play as revolutionary solutions for covid-19 and other pathologies such as Alzheimer’s, cancer, etc. Obesity, diabetes or even anemia.
“An old notebook of my father, an agronomist with a master’s degree at the Hebrew University of Jerusalem, inspired me to start scientific research on plants as a potential cure for the coronavirus,” said Dr. Alkale said who worked before he found the startup. in Israel, New York and London.
Rachel explains that “About a third of the world’s medicines are made from plants. Plants are very interesting targets for researchers looking for new medicines and new ways to treat patients.”
Dr. Alkali started working on an antiviral formula in 2020. His invention was tested in several laboratories and proved that it can block the entry of coronavirus into human cells.
She has worked with some world-renowned laboratories on her discoveries in Israel and at the Center for Infectious Diseases at Canadian McMaster University in Canada.
Rachel Alkaley also looked at Alzheimer’s disease after an early case study with Covid patients who suffered short-term memory loss due to long-term Covid.
“We have developed a new formula that has the potential to prevent and treat Alzheimer’s disease and dementia, improving speech, communication, mobility, mental state, mood, expression of emotions, object recognition, sleep and vitality,” she explains.
“This scientific breakthrough brings a lot of hope and is very good news for people suffering from long-term memory loss, dementia and Alzheimer’s disease. Because it is a plant-based formula, working with safe and legal plants, we hope that “We will be able to market this product in the near future, initially as a dietary supplement,” she continues.
The company is working on other diseases linked to metabolic syndrome, including cancer and diabetes. Regarding diabetes, the product was successfully tested on volunteers with a significant reduction in glucose levels and weight.
